Efficacy, tolerability and safety of once-monthly administration of 75mg risedronate in Japanese patients with involutional osteoporosis: A comparison with a 2.5mg once-daily dosage regimen-Reference-Cited by-同舟云学术

Efficacy, tolerability and safety of once-monthly administration of 75mg risedronate in Japanese patients with involutional osteoporosis: A comparison with a 2.5mg once-daily dosage regimen

Published:2014-02 Issue: Volume:59 Page:44-52
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Hagino Hiroshi,Kishimoto Hideaki,Ohishi Hiroaki,Horii Sayako,Nakamura Toshitaka

Funder

Joint Development Program of Ajinomoto Pharmaceuticals Co., Ltd.

Takeda Pharmaceutical Company Limited

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference29 articles.

1. Japanese 2011 guidelines for prevention and treatment of osteoporosis — executive summary;Orimo;Arch Osteoporos,2012

2. A comparison of incidences of vertebral fracture in Japanese patients with involutional osteoporosis treated with risedronate and etidronate: a randomized, double-masked trial;Kushida;J Bone Miner Metab,2004

3. The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis;Brown;Calcif Tissue Int,2002

4. Two-year results of once-weekly administration of alendronate 70mg for the treatment of postmenopausal osteoporosis;Rizzoli;J Bone Miner Res,2002

5. Therapeutic effects of alendronate 35mg once weekly and 5mg once daily in Japanese patients with osteoporosis: a double-blind, randomized study;Uchida;J Bone Miner Metab,2005

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implications of potential clinically relevant interactions between COVID‐19 vaccines and concomitant medications;Reviews in Medical Virology;2023-04-06

2. Lower bone mineral density can be a risk for an enlarging bone marrow lesion: A longitudinal cohort study of Japanese women without radiographic knee osteoarthritis;Modern Rheumatology;2022-08-03

3. Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women;Cochrane Database of Systematic Reviews;2022-05-03

4. Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D;Cochrane Database of Systematic Reviews;2021-07-07

5. Vaccination for Coronavirus Disease 2019 ( COVID ‐19) and Relationship to Osteoporosis Care: Current Evidence and Suggested Approaches;Journal of Bone and Mineral Research;2021-04-14